Knoll Capital Management, LLC Lipocine Inc. Transaction History

Knoll Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$0.32 - $3.15 $16,000 - $157,500	-50,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.06 - $1.78 $53,000 - $89,000	50,000 New	50,000 $65,000
Q4 2017 Feb 14, 2018	SELL	$3.36 - $4.35 $84,000 - $108,749	-25,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.67 - $4.19 $91,750 - $104,750	25,000	25,000 $99,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $468M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knoll Capital Management, LLC with notifications on news.